A. Roussidis

发表

Imatinib Mesylate Inhibits Proliferation and Exerts an Antifibrotic Effect in Human Breast Stroma Fibroblasts

N. Karamanos, G. Voutsinas, D. Kletsas, 2008, Molecular Cancer Research.

STI571 as a potent inhibitor of growth and invasiveness of human epithelial breast cancer cells.

A. Theocharis, N. Karamanos, D. Kletsas, 2004, Anticancer research.

Expression of MMPs and TIMPs genes in human breast cancer epithelial cells depends on cell culture conditions and is associated with their invasive potential.

A. Theocharis, N. Karamanos, A. Roussidis, 2004, Anticancer research.

The importance of c-Kit and PDGF receptors as potential targets for molecular therapy in breast cancer.

A. Theocharis, G. Tzanakakis, A E Roussidis, 2007, Current medicinal chemistry.

Imatinib as a key inhibitor of the platelet‐derived growth factor receptor mediated expression of cell surface heparan sulfate proteoglycans and functional properties of breast cancer cells

C. Gialeli, D. Kletsas, G. Tzanakakis, 2013, The FEBS journal.

Design, synthesis and cell growth inhibitory activity of a series of novel aminosubstituted xantheno[1,2-d]imidazoles in breast cancer cells.

G. Tzanakakis, P. Marakos, N. Pouli, 2008, Bioorganic & medicinal chemistry.

Small Tyrosine Kinase Inhibitors as Key Molecules in the Expression of Metalloproteinases by Solid Tumors

G. Tzanakakis, A. Roussidis, O. C. Kousidou, 2008, Connective tissue research.

Simultaneous quantification of daptomycin and rifampicin in plasma by ultra performance liquid chromatography: Application to a pharmacokinetic study.

A. Skoutelis, A. Tsarbopoulos, E. Perivolioti, 2010, Journal of pharmaceutical and biomedical analysis.

Development and validation of a UPLC-UV method for the determination of daptomycin in rabbit plasma.

E. Gikas, A. Skoutelis, A. Tsarbopoulos, 2009, Biomedical chromatography : BMC.

Inhibition of receptor tyrosine kinase-based signal transduction as specific target for cancer treatment.

A. Roussidis, Nikos Karamanos, 2002, In vivo.

Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors.

A. Theocharis, D. Kletsas, A. Roussidis, 2005, International journal of oncology.